Clopidogrel and atorvastatin - Significant drug-drug interactions are seen

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
引用
收藏
页码:56GG / 56HH
页数:2
相关论文
共 50 条
  • [1] Higher doses of clopidogrel overcome the atorvastatin-clopidogrel drug-drug interaction
    Lau, WC
    Neer, CJ
    Tait, AR
    Carville, DG
    Guyer, KE
    Bates, ER
    CIRCULATION, 2005, 112 (17) : U349 - U349
  • [2] Clinical significance of the atorvastatin-clopidogrel drug-drug interaction
    Lau, WC
    Carville, DGM
    Bates, ER
    CIRCULATION, 2004, 110 (06) : E66 - E66
  • [3] Investigation of drug-drug interactions between clopidogrel and fluoxetine
    Delavenne, Xavier
    Magnin, Marion
    Basset, Thierry
    Piot, Michele
    Mallouk, Nora
    Ressnikoff, Denis
    Garcin, Arnauld
    Laporte, Silvy
    Garnier, Pierre
    Mismetti, Patrick
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2013, 27 (06) : 683 - 689
  • [4] Drug-drug interactions between clopidogrel and novel cardiovascular drugs
    Pelliccia, Francesco
    Rollini, Fabiana
    Marazzi, Giuseppe
    Greco, Cesare
    Gaudio, Carlo
    Angiolillo, Dominick J.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2015, 765 : 332 - 336
  • [5] Clopidogrel as a Perpetrator of Drug-Drug Interactions: A Challenge for Quantitative Predictions?
    Varma, Manthena V. S.
    Bi, Yi-an
    Lazzaro, Sarah
    West, Mark
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 (06) : 1295 - 1299
  • [6] Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation - A new drug-drug interaction
    Lau, WC
    Waskell, LA
    Watkins, PB
    Neer, CJ
    Horowitz, K
    Hopp, AS
    Tait, AR
    Carville, DGM
    Guyer, KE
    Bates, ER
    CIRCULATION, 2003, 107 (01) : 32 - 37
  • [7] Risk factors for potential clopidogrel drug-drug interactions in stroke patients
    Aleksic, D.
    Toncev, G.
    Drakulic, S. Miletic
    Milosavljevic, M.
    Stefanovic, S.
    Jankovic, S.
    CEREBROVASCULAR DISEASES, 2018, 45 : 101 - 102
  • [8] PREVALENCE AND PREDICTORS OF POTENTIALLY SIGNIFICANT DRUG-DRUG INTERACTIONS IN THE ELDERLY
    Dudash, K.
    Negri, G.
    Baccarini, S.
    Rabinowitz, C.
    Maio, V
    VALUE IN HEALTH, 2011, 14 (03) : A7 - A7
  • [9] Carboxylesterase 1-Mediated Drug-Drug Interactions between Clopidogrel and Simvastatin
    Wang, Xinwen
    Zhu, Hao-Jie
    Markowitz, John Seth
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2015, 38 (02) : 292 - 297
  • [10] A Screening Study of Drug-Drug Interactions in Cerivastatin Users: An Adverse Effect of Clopidogrel
    Floyd, J. S.
    Kaspera, R.
    Marciante, K. D.
    Weiss, N. S.
    Heckbert, S. R.
    Lumley, T.
    Wiggins, K. L.
    Tamraz, B.
    Kwok, P-Y
    Totah, R. A.
    Psaty, B. M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 91 (05) : 896 - 904